Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenocarcinoma, Clear Cell (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Breast Neoplasms (Phase 1)
Carcinoma, Basal Cell (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 1)
Carcinoma, Squamous Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Cholangiocarcinoma (Phase 1)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 1)
Hodgkin Disease (Phase 2)
Melanoma (Phase 1)
Mesothelioma (Phase 2)
Nasopharyngeal Carcinoma (Phase 1)
Neoplasms (Phase 2)
Neoplasms, Adnexal and Skin Appendage (Phase 1)
Ovarian Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1)
Rectal Neoplasms (Phase 2)
Salivary Gland Neoplasms (Phase 1)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Thymoma (Phase 1)
Thyroid Neoplasms (Phase 2)
Tuberculosis, Extrapulmonary (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Vulvar Neoplasms (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue